Fatty liver disease (MASLD/MASH): open trials in Portugal

3 open trials have a site in Portugal. Registry data; only the trial team decides who can take part.

NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Associacao Protectora Dos Diabeticos De Portugal, Lisbon · Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisbon
Registry updated 2026-10-08
NCT05651724
Global Research Initiative for Patients Screening on MASH
Research · Julius Clinical
ULSSM - Unidade Local de Saúde Santa Maria, E.P.E, Lisbon
Registry updated 2024-08-01
NCT04442334
The European NAFLD Registry
Research · Newcastle University
Hospital De Santa Maria, Lisbon
Registry updated 2023-01-06

This page is not medical advice. Talk to your doctor before contacting a trial.

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)